Revolution Medicines, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 17.10 M | $747.80 M | 14.65% | 10.25% |
BLACKROCK, INC. | 02/07/2025 | 14.72 M | $643.83 M | 6.15% | 8.82% |
FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 13.25 M | $579.50 M | 17.06% | 7.94% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 10.82 M | $473.34 M | -5.08% | 6.49% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 9.48 M | $414.78 M | 54.53% | 5.68% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 7.94 M | $347.16 M | 4.86% | 4.76% |
NEXTECH INVEST LTD. | 02/14/2025 | 7.60 M | $332.47 M | 20.71% | 4.56% |
FMR LLC | 02/13/2025 | 6.74 M | $294.90 M | 14.74% | 4.04% |
PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 6.55 M | $286.63 M | 23.32% | 3.93% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 5.87 M | $256.58 M | 10.40% | 3.52% |
STATE STREET CORP | 02/14/2025 | 5.79 M | $253.33 M | 9.70% | 3.47% |
BELLEVUE GROUP AG | 02/14/2025 | 4.39 M | $191.88 M | -9.95% | 2.63% |
02/14/2025 | 4.28 M | $187.18 M | 100.00% | 2.56% | |
BVF INC/IL | 02/14/2025 | 4.18 M | $182.88 M | 20.20% | 2.51% |
ALPHABET INC. | 02/07/2025 | 4.13 M | $180.79 M | -2.89% | 2.48% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 4.09 M | $180.17 M | 12.66% | 2.45% |
WOODLINE PARTNERS LP | 02/14/2025 | 3.89 M | $169.96 M | 13.16% | 2.33% |
JPMORGAN CHASE & CO | 02/12/2025 | 3.83 M | $167.50 M | -7.46% | 2.30% |
CASDIN CAPITAL, LLC | 02/14/2025 | 3.70 M | $161.81 M | -10.09% | 2.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.26 M | $142.52 M | 11.87% | 1.95% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 3.00 M | $131.08 M | 39.41% | 1.80% |
AH CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 2.75 M | $120.22 M | 0.00% | 1.65% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.63 M | $115.04 M | 11.70% | 1.58% |
LUNATE HOLDING RSC LTD | 02/14/2025 | 2.20 M | $96.06 M | 100.00% | 1.32% |
LORD, ABBETT & CO. LLC | 02/14/2025 | 1.98 M | $86.55 M | 8.01% | 1.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.93 M | $84.47 M | 9.53% | 1.16% |
NORGES BANK | 02/12/2025 | 1.74 M | $76.20 M | 100.00% | 1.04% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.68 M | $73.41 M | 25.93% | 1.01% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 1.63 M | $71.16 M | 9.52% | 0.98% |
NORTHERN TRUST CORP | 02/14/2025 | 1.54 M | $67.36 M | 17.45% | 0.92% |
MARSHALL WACE, LLP | 02/13/2025 | 1.50 M | $65.82 M | 41.30% | 0.90% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 1.45 M | $63.42 M | 20.83% | 0.87% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 1.30 M | $56.99 M | -21.13% | 0.78% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.21 M | $53.07 M | 20.13% | 0.73% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 997.46 K | $43.63 M | 0.00% | 0.60% |
MORGAN STANLEY | 02/14/2025 | 858.28 K | $37.54 M | 31.47% | 0.51% |
POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 750.67 K | $32.83 M | 100.00% | 0.45% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 712.60 K | $31.17 M | 4,399.56% | 0.43% |
FINEPOINT CAPITAL LP | 02/13/2025 | 710.26 K | $31.07 M | -2.96% | 0.43% |
CANDRIAM S.C.A. | 02/07/2025 | 656.74 K | $28.73 M | 16.49% | 0.39% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 650.00 K | $28.43 M | 124.14% | 0.39% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 641.65 K | $28.07 M | 11.13% | 0.38% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 631.18 K | $27.61 M | 21.85% | 0.38% |
SIREN, L.L.C. | 02/14/2025 | 571.55 K | $25.00 M | -24.16% | 0.34% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 569.02 K | $24.89 M | 6.90% | 0.34% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 550.00 K | $24.06 M | 57.14% | 0.33% |
MIC CAPITAL MANAGEMENT UK LLP | 02/14/2025 | 508.57 K | $22.24 M | 0.00% | 0.30% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 473.73 K | $20.72 M | 3.13% | 0.28% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 446.20 K | $19.52 M | -43.52% | 0.27% |
JANE STREET GROUP, LLC | 02/14/2025 | 433.40 K | $18.96 M | 68.70% | 0.26% |
Revolution Medicines, Inc. institutional Ownership - FAQ's
During the previous two years, 263 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
BARTLETT & CO. WEALTH MANAGEMENT LLC: 0
Riverview Trust Co: 0
Continuum Advisory, LLC: 0
FISHMAN JAY A LTD/MI: 0
Cambridge Investment Research Advisors, Inc.: 0
Hexagon Capital Partners LLC: 0
115.71% of Revolution Medicines, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 195.53 M shares in the last 24 months. This purchase volume represents approximately $7.93 B in transactions.